Who Paid My Doc
Yasmin Shayesteh
Ophthalmic Plastic and Reconstructive Surgery Everett, WA Medical Doctor
NPI 1891940334 CMS profile 312584
3901 Hoyt Ave, Everett, WA 98201
General payments
$261
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Yasmin Shayesteh of Everett, WA is reported in the CMS Open Payments database as having received $261 across 3 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 11th percentile of Ophthalmic Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $23 | 1 | |
| 2020 | General | $125 | 1 | |
| 2019 | General | $113 | 1 |
Beside peers
- Yasmin Shayesteh
- Ophthalmic Plastic and Reconstructive Surgery median
- Middle half of Ophthalmic Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Yasmin Shayesteh were reported at $0. Among 325 Ophthalmic Plastic and Reconstructive Surgery profiles paid that year, the median was $298 and the middle half received between $132 and $820.
Show as a table
| Year | Yasmin Shayesteh | Ophthalmic Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $113 | $182 | $73–$467 | $163 |
| 2020 | $125 | $125 | $41–$412 | $114 |
| 2021 | $0 | $173 | $52–$538 | $132 |
| 2022 | $0 | $237 | $78–$809 | $149 |
| 2023 | $23 | $291 | $103–$776 | $160 |
| 2024 | $0 | $304 | $108–$822 | $164 |
| 2025 | $0 | $298 | $132–$820 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
266
Drug cost
$732,757
Branded share of claims
94.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Tepezza Teprotumumab-Trbw | Brand | 11 | $729,661 | |
| Erythromycin Erythromycin Base | Brand | 200 | $2,552 | |
| Bacitracin-Polymyxin Bacitracin/Polymyxin B Sulfate | Brand | 14 | $205 | |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | Brand | 15 | $199 | |
| Cephalexin | Generic | 14 | $104 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 12 | $37 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,260 Part D prescribers listed as Ophthalmology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 39 billing codesPaid by Medicare
$37,409
Medicare patients
116
Services billed
303
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 63% | |
| Arthritis | 47% | |
| Diabetes | 22% | |
| Depression | 22% | |
| Ischemic heart disease | 20% | |
| Chronic kidney disease | 20% | |
| Cancer | 18% | |
| Atrial fibrillation | 16% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Ophthalmic Plastic and Reconstructive Surgery in Washington
Peter Kally
Ophthalmic Plastic and Reconstructive Surgery · Seattle, WA
Shu Hong Chang
Ophthalmic Plastic and Reconstructive Surgery · Seattle, WA
John Heffernan
Ophthalmic Plastic and Reconstructive Surgery · Tacoma, WA
Jason Lewis
Ophthalmic Plastic and Reconstructive Surgery · Tacoma, WA
Harkaran Rana
Ophthalmic Plastic and Reconstructive Surgery · Tacoma, WA
Matthew Hauck
Ophthalmic Plastic and Reconstructive Surgery · Vancouver, WA
Related records
Ophthalmic Plastic and Reconstructive Surgery in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Ophthalmic Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.